- Home
- CX vs ELAN Comparison
CX vs ELAN Comparison
Compare CX & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CX
- ELAN
- Stock Information
- Founded
- CX 1906
- ELAN 1954
- Country
- CX Mexico
- ELAN United States
- Employees
- CX N/A
- ELAN N/A
- Industry
- CX Building Materials
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- CX Industrials
- ELAN Health Care
- Exchange
- CX Nasdaq
- ELAN Nasdaq
- Market Cap
- CX 12.2B
- ELAN 10.3B
- IPO Year
- CX 1999
- ELAN 2018
- Fundamental
- Price
- CX $10.27
- ELAN $22.59
- Analyst Decision
- CX Buy
- ELAN Buy
- Analyst Count
- CX 7
- ELAN 8
- Target Price
- CX $10.52
- ELAN $20.00
- AVG Volume (30 Days)
- CX 10.8M
- ELAN 4.7M
- Earning Date
- CX 10-28-2025
- ELAN 11-05-2025
- Dividend Yield
- CX 0.84%
- ELAN N/A
- EPS Growth
- CX 293.85
- ELAN N/A
- EPS
- CX 0.09
- ELAN 0.88
- Revenue
- CX $15,869,840,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- CX $2.64
- ELAN $5.77
- Revenue Next Year
- CX $4.82
- ELAN $4.96
- P/E Ratio
- CX $10.99
- ELAN $25.81
- Revenue Growth
- CX N/A
- ELAN N/A
- 52 Week Low
- CX $4.89
- ELAN $8.02
- 52 Week High
- CX $10.45
- ELAN $22.73
- Technical
- Relative Strength Index (RSI)
- CX 70.15
- ELAN 75.70
- Support Level
- CX $9.30
- ELAN $21.80
- Resistance Level
- CX $9.75
- ELAN $22.45
- Average True Range (ATR)
- CX 0.29
- ELAN 0.61
- MACD
- CX 0.07
- ELAN 0.07
- Stochastic Oscillator
- CX 86.84
- ELAN 95.87
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.